Evidence map›Paper›PMID 32222809›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

CTumorGAN: a unified framework for automatic computed tomography tumor segmentation.

Shuchao Pang, Anan Du, Mehmet A Orgun, Zhenmei Yu, Yunyun Wang, Yan Wang, Guanfeng Liu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuchao PangDepartment of Computing, Macquarie University, Sydney, NSW, 2109, Australia.
Anan DuSchool of Electrical and Data Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Mehmet A OrgunDepartment of Computing, Macquarie University, Sydney, NSW, 2109, Australia. mehmet.orgun@mq.edu.au.
Zhenmei YuSchool of Data and Computer Science, Shandong Women's University, Jinan, 250014, China.
Yunyun WangDepartment of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, 130012, China.
Yan WangDepartment of Computing, Macquarie University, Sydney, NSW, 2109, Australia.
Guanfeng LiuDepartment of Computing, Macquarie University, Sydney, NSW, 2109, Australia.

Funding

Macquarie University iMQRES: 2018150National Natural Science Foundation of China 61472416
6 · The paper itself

Abstract

purposeUnlike the normal organ segmentation task, automatic tumor segmentation is a more challenging task because of the existence of similar visual characteristics between tumors and their surroundings, especially on computed tomography (CT) images with severe low contrast resolution, as well as the diversity and individual characteristics of data acquisition procedures and devices. Consequently, most of the recently proposed methods have become increasingly difficult to be applied on a different tumor dataset with good results, and moreover, some tumor segmentors usually fail to generalize beyond those datasets and modalities used in their original evaluation experiments.

methodsIn order to alleviate some of the problems with the recently proposed methods, we propose a novel unified and end-to-end adversarial learning framework for automatic segmentation of any kinds of tumors from CT scans, called CTumorGAN, consisting of a Generator network and a Discriminator network. Specifically, the Generator attempts to generate segmentation results that are close to their corresponding golden standards, while the Discriminator aims to distinguish between generated samples and real tumor ground truths. More importantly, we deliberately design different modules to take into account the well-known obstacles, e.g., severe class imbalance, small tumor localization, and the label noise problem with poor expert annotation quality, and then use these modules to guide the CTumorGAN training process by utilizing multi-level supervision more effectively.

resultsWe conduct a comprehensive evaluation on diverse loss functions for tumor segmentation and find that mean square error is more suitable for the CT tumor segmentation task. Furthermore, extensive experiments with multiple evaluation criteria on three well-established datasets, including lung tumor, kidney tumor, and liver tumor databases, also demonstrate that our CTumorGAN achieves stable and competitive performance compared with the state-of-the-art approaches for CT tumor segmentation.

conclusionIn order to overcome those key challenges arising from CT datasets and solve some of the main problems existing in the current deep learning-based methods, we propose a novel unified CTumorGAN framework, which can be effectively generalized to address any kinds of tumor datasets with superior performance.

Indexed as

Liver NeoplasmsLung NeoplasmsDatabases, FactualHumansImage Processing, Computer-AssistedTomography, X-Ray ComputedAdversarial learningComputed tomography (CT)Conditional generative adversarial networks (cGAN)Loss functionTumor segmentation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.